Form D · Pharmaceuticals
PCA Benefits, Inc.
Englewood, NJ · CIK 0001560321
Offering snapshot reported Oct 15, 2012 · SEC filing
- Reported sold
- $5.93M Offering amount: $5.93M
- Investors reported
- 21 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 19, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 15, 2012 | Initial | $5,925,000 | No comparison | 21 | SEC filing |
Offering details
- Securities
- Equity, Debt
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $415K
- Finders' fees
- $0
- Form D file number
- 021-185550
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Chardan Capital Markets, LLC | 120128 |
Source: Form D, filed Oct 15, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Hemil Khandwala | Director |
| John M. Phelps | Director |
| Ann F. Saskowitz | Director, Executive |
| Gary J. Sekulski | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
74 Grand Avenue Second Floor
Englewood, NJ, 07631
Englewood, NJ, 07631